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Objectives. Patients with PAD may have severe symptoms from their lower extremities as well as a 3-4 fold increased risk
of death due to systemic atherosclerosis. The purpose of this study was to identify whether treatment goals of a nurse led
rehabilitation clinic were achieved.
Design. Prospective cohort study over 4 year period to May 2004.
Methods. All patients with symptomatic PAD were offered enrolment in a nurse-led rehabilitation clinic and given advice
on diet and exercise. All smokers were offered smoking cessation advice and treatment. Anti-platelet therapy was prescribed
to all patients and statin therapy was prescribed to those with dyslipidemia.
Results. 693 patients with symptomatic PAD were prospectively entered into the clinic (total 2563 clinic visits). Average
age was 67 years and 53% were males. Some (167, 24%) were included for non-surgical treatment and most (526, 76%)
were included as part of their postoperative follow-up. After 6 months, the proportion of patients taking platelet inhibitors
and statins had increased from 63% and 27% to 87% and 84% respectively. Mean total cholesterol was reduced from
6.2 mmol/l to 4.9 mmol/l and mean LDL cholesterol from 3.9 mmol/l to 2.6 mmol/l. After 1 year the proportion of smokers
was reduced from 59% to 51.5% (12.5% relative reduction).
Conclusion. This nurse-driven rehabilitation clinic has proven effective in reaching medication targets for secondary pre-
vention. Smoking cessation was less successful.
Keywords: PAD; Prevention; Life style; Cholesterol; Statins; Platelet inhibitors.Introduction
Peripheral arterial disease (PAD) is associated with
a significantly increased morbidity and mortality
due to the generalised nature of atherosclerosis. The
risk of dying from coronary artery disease (CAD) is
increased by a factor 2e4 depending on the severity
of the lower limb disease.1e4 Thus, it is recommended,
that patients with PAD should receive advice on life
style changes and prophylactic medical therapy for
secondary prevention to reduce the risk of atheroscle-
rotic complications.5e9
Traditionally, vascular surgeons (and interven-
tional radiologists) have focused on measures related
to improving symptoms from the lower limb(s) and,
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PAD patients, or referred patients to other physicians
for treatment of the underlying atherosclerotic dis-
ease. However, recent data have shown that the for-
mer situation appears to be more common than the
latter, with data from primary care being disappoint-
ing. The number of patients receiving proper counsel-
ling and medical therapy has been disappointing
low.3,10e13
In our own department, we surveyed patients op-
erated mainly for critical limb ischemia during 1998
and found the level of medical treatment to be poor:
only 39% of patients were on aspirin and 5% were re-
ceiving lipid lowering drugs (statins), even though
almost 40% had established coronary artery disease,
CAD.3 Since no other medical specialty had shown
interest in undertaking the preventive task in these
patients, the perception of PAD as a CAD equivalent
among primary care physicians (PCP) has not been
established. Because all patients treated in our unitrved.
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low ups (1 month and 1 year after treatment), we de-
cided to organise our own PAD rehabilitation clinic.
This paper describes the organisation of the clinic,
Gang-I-Gen (GIG) at Gentofte University Hospital
and the results obtained since the start in year 2000
until May 2004.
Patients and Methods
Development of the concept: From the beginning, it was
realised, that the time needed to offer proper counsel-
ling, especially with relation to changes in life style,
was much more than the surgical staff could provide
in a meaningful manner. Thus, it was decided that
nurses, following written guidelines (available as
Web Supplement), should be the main driving force
in the rehabilitation clinic, under supervision and re-
sponsibility of the vascular surgeons. The premise
was for a nurse to offer all simple preventive mea-
sures needed by patients with atherosclerotic manifes-
tations: informing the patient in such a manner that
they individually would be able to make decisions
on life-style changes with respect to smoking cessa-
tion, regular physical exercise and eating habits. The
information given had in each case to be adjusted to
the patients existing knowledge, need and motivation
for changes in life-style. Also, the clinic should focus
on appropriate medication for secondary prevention,
including anti-platelet and lipid-lowering drugs.
Treatment of other risk factors, e.g. hypertension or
diabetes was attempted. However, when hyperten-
sion and diabetes was diagnosed patients were re-
ferred for treatment.
In order to monitor the activity and evaluate
whether treatment goals were reached, a database
was developed (GiG software). The records included
data on other atherosclerotic manifestations, risk fac-
tors, previous interventions, details of lower limb
symptoms and objective findings, laboratory values,
advice and medications (see description below). At
every visit to the clinic, new data would be entered.
All information was kept electronically, however,
the date of the visit was stamped in the chart to indi-
cate that a visit to the clinic had taken place. Also,
a specific printout from the database was put into
the chart with a short summary of findings i.e. vital
signs, lab values and a short description of specific
problems or arrangements. Additionally, a 2-page
printout was generated for the patient with 6 graphs
showing the historic development of their blood pres-
sure, ankle-brachial index (ABI), lipid values, weight,
smoking status and self reported walking distance
(Fig. 1). Results of clinic blood tests were availablewithin 1 hour, so that results could be immediately
discussed with the patient.
In September 2002, all nurses in the outpatient clinic
(6 nurses) were trained to offer the counselling/
treatment. This included training as ‘‘smoking cessa-
tion instructor’’, increased level of knowledge with
regard to nutrition for patients with atherosclerosis
and knowledge about theories behind changes of
habits/life-style according to Prochaska and DiCle-
mentes.14 Thus, the vascular nurses, who already
were capable of measuring ankle pressures, wound
treatment and duplex scanning, were also able to give
counselling and oversee the preventive treatments.
Organisation of the clinic. The attending vascular
surgical consultant saw all new referrals. If interven-
tional treatment was considered immediately, advice
on life-style changes were given briefly by the consul-
tant, but the GiG consultation was postponed until af-
ter the final treatment plan was made or executed. It
was felt to be very important, that the consultant do-
ing the initial evaluation of the patient, would explain
the importance of the life style changes and medical
therapy.
The time needed for a nurse to do a consultation
varied depending on whether it was the first GiG visit
for the patient and on which life style interventions
were needed. Additional time could be needed for
wound care, postoperative follow-up and/or an ultra-
sound examination and data entry. The average nurse
consultation lasted 45e60 minutes.
GiG counselling was offered to all patients referred
to the department of vascular surgery not already en-
rolled into health prevention programmes, such as
those for patients with diabetes. Patients were offered
5 visits over one year, or 5 visits within the year after
surgery. Intervals were 6 weeks between visit 1,2 and
3, 3 months between 3 and 4 and 6 months before the
last visit.
Description of the GiG software. The Danish Data Reg-
ulatory Authority gave permission to keep the elec-
tronic patient data for this study. The database holds
up to 100 variables covering medical history, risk fac-
tors, present symptoms and measurements with focus
on the lower extremities, and data on counselling and
laboratory values. Most fields are coded with either
yes/no or a one-digit code for different conditions.
Many of the codes entered will be carried forward to
the next visit and only require attention if the patients
condition has changed. A section on medication allows
for entering prescriptions. A section for comments al-
lows for entering free text when necessary. The last
section is the printout/analysis module. Patient
print-outs are educational (for the patient to become
more responsible for his/her targets), can be shownEur J Vasc Endovasc Surg Vol 33, January 2007
28 H. Sillesen et al.Fig. 1. Page 1 of the patient report (fictive patient, original text inDanish), showingdevelopment in cholesterol values (top left),
blood pressure (top right), ankle-brachial index (bottom left) and self reported walking distance (bottom right). Page 2 (not
shown) illustrates tobacco use and weight changes over time, lists medications and gives the date and time for next visit.to family members or the patient’s family practioner
(Fig. 1). Finally, it also shows a list of prescribed med-
ications, the date of the next visit in addition to simple
advice on healthy behaviour. The printout for the
patient chart includes basic variables like ABI, lab tests
and the written text if any. Standard letters for patients
family practitioner can be generated when patients en-
ter the GiG rehabilitation clinic and when they finish,
including laboratory results, medications etc.
Data analysis. Data were analysed using SPSS ver-
sion 12.00.2. Continuous data were compared withEur J Vasc Endovasc Surg Vol 33, January 2007paired t-test and categorical data with c2-test. Change
in walking distance was compared with Wilcoxon
signed rank test. A two-sided p value 0.05 was con-
sidered statistical significant.
Results
Thefirst patient entered theGiG clinic inApril 2000 and
by May 1st 2004 693 patients had been enrolled. By
September 2004, all patients had a minimum of one
follow-up visit and the total number of GiG clinic visits
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are shown in Table 1: the mean age was 67 years and
53% were male. One hundred and sixty seven (24%)
patients without open surgical or endovascular inter-
vention (patients with intermittent claudication) and
526 (76%) patients were included as part of their post-
operative follow-up (for peripheral balloon angio-
plasty, peripheral thrombo-endarterectomy or bypass).
The medications of the patients are shown in Fig. 2.
At entry, 63% of patients were taking aspirin and 27%
statins. After 6 months these numbers had increased
to 87% and 84% respectively. At 12 months the
numbers were approximately the same: 88% and
92% respectively. The use of antihypertensive drugs,
beta-blockers and ACE-inhibitors remained at a low
level throughout the 12-month period.
At entry, mean total cholesterol value was
6.2 mmol/L (Standard error (SE) 0.05 mmol/L) and
mean LDL was 3.9 mmol/L (SE 0.05 mmol/L)
(Fig. 3). After 6 months there was a mean reduction
of 23% ( p< 0.0001) in total cholesterol to 4.9 mmol/
L (SE 0.05 mmol/L) and 34% ( p< 0.0001) in LDL cho-
lesterol to 2.6 mmol/L (SE 0.04 mmol/L). At 12
months the cholesterol reduction was slightly greater:
24% ( p< 0.0001) and 35% ( p< 0.0001) for total and
LDL cholesterol respectively. Most patients (78%)
met the Danish recommendations for patients with
atherosclerotic disease, which, until September 2003,
was total cholesterol< 5 mmol/l and LDL< 3 mmol/l,
by 12 months.
At clinic entry 59% patients were smokers and 5%
patients claimed that they had never smoked
(Fig. 4). By 6 months the proportion had decreased
to 54.8% and at 1 year to 51.5% (12,5% of smokers
stopped smoking during their participation in the
GiG rehabilitation programme). The mean blood
Table 1. Characteristics of Patients
Number 693
Male gender, % 53
Age, (range) 67 (range 32e93)
Diabetes, % 15.2
Body mass index, kg/m2 25.9 (CI: 8.3)
Cardiovascular disease
Angina, % 12.9
Myocardial infarction, % 13.2
Central revascularization,
CABG/PTCA, %
7.1
Stroke or TIA 14.8
Atrial fibrilation, % 3.4
ABI Right/Left 73.0(CI: 44.7), 73.2(CI: 42.3)
CI: 95% confidence intervals.
CAGB: coronary artery bypass graft.
PTCA: percutaneous transluminal coronary angioplasty.
TIA: transient ischemic attacks.
ABI: Ankle Brachial Index.pressure on entry was 153/79 mmHg. By 6 months
this had fallen to 148/77 mmHg and remained at
this level at 12 months (148/76 mmHg) ( p< 0.0001).
Self reported walking distance increased in the
group treated without surgical or endovascular inter-
vention: median walking distance of 200 m (range 0e
3000 m) at entry increased to 800 m (range 0e10,000
meter) after 6 months, p< 0.001.
Meanweightat entrywas75 kg (range37e127 kg)and
after 12 months mean weight 74 kg (range 39e122 kg).
Discussion
The targets for secondary prevention medication were
achieved in this nurse-led clinic.
Most patients (88%) were prescribed platelet inhib-
itors. Since some patients may have contraindications
or otherwise not tolerate aspirin or clopidogrel, better
targets are probably unrealistic. On entry to the clinic
only 27% patients had been prescibed cholesterol low-
ering drugs (statins), but by 1 year nearly all patients
(92%) had been prescribed a statin. This result clearly
reflects the seriousness with which dyslipidemia is re-
garded within our institution. Both these results show
a major improvement compared to our data from
1998.3 These good results we present may relate to
the fact that patients had to actively accept participa-
tion to join the rehabilitation clinic. Thus, less moti-
vated patients might not have accepted the offer,
thereby making the results seem better. On the other
hand, patients who were already well treated or
who were attending another rehabilitation pro-
gramme were not included. Also, our very high rate
of prescription of antiplatelet drugs and statins does
not necessarily imply that patients are taking these
drugs (compliance), however, the average level of
cholesterol achieved and the high percentage reaching
treatment goals indicates that many of our patients
were changing behaviour and taking the prescribed
medicine.
There is accumulating evidence that patients with
PAD are not offered secondary prevention as often
as patients with CAD. In a survey among Danish Gen-
eral Practitioners15 only 27% of patients with diag-
nosed PAD were prescribed statins compared to 75%
in patients with coronary heart disease. In a British
study of patients referred for vascular surgical evalu-
ation due to PAD, 78% were found to be prescribed
aspirin and 38% a statin.9 In two recent North Amer-
ican studies, also of PAD patients who had undergone
revascularization, 72% were found to be prescribed
anti-platelet agents12 and only 31% and 50% were pre-
scribed statins.12,13 In the recent REACH registry 81%Eur J Vasc Endovasc Surg Vol 33, January 2007
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Fig. 2. The use of drugs in Patients entering GiG from entry until 12 months control.of PAD patients were found to on antiplatelet medica-
tion and 64% on a statin.16 PAD patients have a lower
chance of being prescribed preventive medications by
family practioners as compared to patients suffering
CAD.12,15,17 In this latter study, McDermott et al.17
found that vascular surgeons had highest threshold
for initiation of statin therapy as compared to cardiol-
ogists, general internists and family practitioners. This
leaves a serious educational challenge for vascular
surgeons.
The success of the rehabilitation clinic in prescribing
medical therapy was not matched by success in smok-
ing cessation, only 12.5% of smokers actually stopped
smoking during the reported year of attendance atEur J Vasc Endovasc Surg Vol 33, January 2007the clinic: much less than some reported studies. In
the retrospective study of Youssef et al.,21 half of the at-
tending PAD patients, who were active smokers,
stopped smoking. Similar results were found by The
Vestfold Heartcare Study Group22 investigating pa-
tients with CAD. Also Froelicher et al.23 found that
approximately 50%of patientswith cardiovascular dis-
ease would stop smoking, however, being randomised
to attend a nurse-managed cognitive behavioural re-
lapse-prevention intervention did not result in a signif-
icant higher number who stopped smoking.
Our rehabilitation concept is evolving and treat-
ment of hypertension is now being included when
necessary. All pre-operative patients are prescribed0
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Fig. 3. Development of cholesterol values over time.
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Fig. 4. Changes in smoking status over time.a beta-blocker for the perioperative period and un-
treated patients with mild or moderate hypertension
are prescribed ramipril (ACE-inhibitor).18e20 A simi-
lar clinic has been established at Rigshospitalet, also
in Copenhagen, and the vascular nurses in the two
hospitals meet regularly to exchange experience and
to give input to future modifications of the concept.
A future challenge will be to secure the continuing
high levels of patient care, after one year of clinic at-
tendance, when they are returned to the care of their
family practioner.
Conclusion: A nurse-led clinic within a vascular
surgical setting, working to strict guidelines, is effec-
tive in establishing medical therapy for secondary
prevention for PAD patients. Further developments
to improve smoking cessation will be required.
Appendix. Supplementary data
Supplementary data associated with this article
can be found, in the online version, at 10.1016/
j.ejvs.2006.07.022
References
1 DORMANDY J, HEECK L, VIG S. The natural history of claudication:
risk to life and limb. Semin Vasc Surg 1999;12:123e137.
2 CRIQUI MH, LANGER RD, FRONEK A, FIEGELSON HS, KLAUBER MR,
MCCANN TJ et al. Mortality over a period of 10 years in patients
with peripheral arterial disease. N Engl J Med 1992;328:
381e386.
3 BISMUTH J, KLITFOD L, SILLESEN H. The lack of management of con-
comitant coronary disease in patients with peripheral atheroscle-
rotic disease. Eur J Vasc Endovasc Surg 2001;21:143e146.
4 MULUK SC, MULUK VS, KELLEY ME. Outcome events in patients
with claudication: a 15-year study in 2777 patients. J Vasc Surg
2001;33:251.5 Management of peripheral arterial disease (PAD). TransAtlantic
Inter-Society Consensus (TASC). Eur J Vasc Endovasc Surg 2000;
19:S144eS243.
6 GRUNDY SM, CLEEMAN JI, MERZ CNB, BREWER HB, CLARK LT,
HUNNUNGHAKE DB et al. Implications of Recent Clinical Trials for
theNationalCholesterol EducationProgramAdult TreatmentPanel
III Guidelines. Circulation 2004;110:227e239.
7 HIATT WR. Medical treatment of peripheral arterial disease and
claudication. N Engl J Med 2001;344:1608e1621.
8 Heart Protection Study. Lancet 2002;360:7e22.
9 Collaborative meta-analysis of randomised trials of antiplatelet
therapy for prevention of death, myocardial infarction, and
stroke in high risk patients. BMJ 2002;324:71e86.
10 NASS CM, ALLEN JK, JERMYN RM, FLEISCHER LA. Secondary pre-
vention of coronary artery disease in patients undergoing
elective surgery for peripheral artery disease. Vasc Med 2001;6:
35e41.
11 BURNS P, LIMA E, BRADBURYAW. Second best medical therapy. Eur J
Vasc Endovasc Surg 2002;24:400e404.
12 MUKHERJEE D, LINGAM P, CHETCUTI S, GROSSMAN PM, MOSCUCCI M,
LUCIANO AE et al. Missed Opportunities to Treat Atherosclerosis
in Patients Undergoing Peripheral Vascular Interventions.
Circulation 2002;106:1909e1912.
13 REHRING TF, SANDHOFF BG, STOLCPART RS, MERENICH JA,
HOLLIS HW. Atherosclerosis risk factor control in patients
peripheral arterial disease. J Vasc Surg 2005;41:816e822.
14 PROCHASKA JO, NORCROSS JC, DICLEMENTES CC. Changing for good:
a revolutionary sixstage program for overcoming bad habits and
moving your life positively forward. New York: Avon Books;
1994.
15 ELDRUP N, SILLESEN H. Perifer atherosklerose: forebyggelse
og behandling. Ma˚nedsskrift for Praktisk Lægegerning 2004;82:
711e720.
16 BHATT DL, STEG PG, OHMAN EM. International prevalence, recog-
nition and treatment of cardiovascular risk factors in outpatients
with atherothrombosis. JAMA 2006;295:180e189.
17 MCDERMOTT MM, HAHN EA, GREENLAND P, CELLA D, OCKENE JK,
BROGAN D et al. Atherosclerotic risk factor modification in pe-
ripheral arterial disease. Results of a national survey. J Gen Intern
Med 2002;17:895e904.
18 MANGANO DT, LAYUG EL, WALLACE A, TATEO I. Effect of atenolol on
mortality and cardiovascular morbidity after noncardiac
surgery. Multicenter Study of Perioperative Ischemia Research
Group. N Engl J Med 1996;335:1713e1720.
19 POLDERMANS D, BOERSMA E, BAX JJ, THOMSON IR, PAELINCK B, VAN DE
VEN LL et al. Bisoprolol reduces cardiac death and myocardialEur J Vasc Endovasc Surg Vol 33, January 2007
32 H. Sillesen et al.infarction in high-risk patients as long as 2 years after successful
major vascular surgery. Eur Heart J 2001;22:1353e1358.
20 ØSTERGREN J, SLEIGHT P, DAGENAISC G, DANISAD K, BOSCHE J,
QILONGE YI et al. Impact of ramipril in patients with evidence
of clinical or subclinical peripheral arterial disease. Eur Heart J
2004;25:17e24.
21 YOUSSEF F, GUPTA P, MIKHAILIDIS P, HAMILTON G. Risk modification
in patients with peripheral arterial disease: a retrospective sur-
vey. Angiology 2005;56:279e287.
22 The Vestfold Heartcare Study Group. Influence on life style mea-
sures and five-year coronary risk by a comprehensive life styleEur J Vasc Endovasc Surg Vol 33, January 2007intervention programme in patients with coronary heart disease.
Eur J Cardiovasc Prev Rehabil 2003;10:429e437.
23 FROELICHER ESS, MILLER NH, CHRISTOPHERSON NJ, MARTIN K,
PARKER KM, AMONETTI M et al. High rates of sustained smoking
cessation in women hospitalized with cardiovascular disease.
The Women’s Initiative for Nonsmoking (WINS). Circulation
2004;109:587e593.
Accepted 11 July 2006
Available online 25 October 2006
